Division of Allergy Pulmonary and Critical Care Medicine Archive — Page 9 of 12
-
April 18, 2019
Medical Societies honor multiple Vanderbilt faculty
Several Vanderbilt faculty members were recently honored during the joint annual meeting of the Association of American Physicians (AAP) and American Society for Clinical Investigation (ASCI). -
February 18, 2019
VUMC study finds helping patients breathe during intubation prevents life-threatening complications
Thousands of Americans die each year during a dangerous two-minute procedure to insert a breathing tube. Now a Vanderbilt University Medical Center (VUMC) study in the New England Journal of Medicine (NEJM) is showing that using bag-mask ventilation, squeezing air from a bag into the mouth for 60 seconds to help patients’ breathing, improves outcomes and could potentially save lives. -
February 7, 2019
Symposium shines light on research by medical students
The Vanderbilt University School of Medicine Medical Scholars Research Symposium was held Feb. 4 and highlighted the work of eight medical students who spent the 2017-2018 academic year immersed in research experiences under the guidance of faculty mentors. -
October 22, 2018
Antipsychotics ineffective for treating ICU delirium: study
Critically ill patients are not benefiting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine. -
October 4, 2018
New center formed to treat, study ICU delirium, dementia
Millions of patients in intensive care units each year develop delirium during their hospitalization and often leave the hospital with cognitive deficits similar to those suffering from traumatic brain injury or mild Alzheimer’s disease. -
August 2, 2018
Connecting an asthma gene to leukemia
A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered. -
July 12, 2018
Team explores diabetes drug’s ability to treat RSV infection
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.